Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control (2022)

First Author: Gandasegui J

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(22)00369-3

PubMed Identifier: 35850127

Publication URI: http://europepmc.org/abstract/MED/35850127

Type: Journal Article/Review

Parent Publication: The Lancet Infectious Diseases

Issue: 11

ISSN: 1473-3099